[go: up one dir, main page]

US6733690B1 - Laterally substituted curable liquid crystals - Google Patents

Laterally substituted curable liquid crystals Download PDF

Info

Publication number
US6733690B1
US6733690B1 US09/936,725 US93672501A US6733690B1 US 6733690 B1 US6733690 B1 US 6733690B1 US 93672501 A US93672501 A US 93672501A US 6733690 B1 US6733690 B1 US 6733690B1
Authority
US
United States
Prior art keywords
group
coo
diyl
ooc
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09/936,725
Inventor
Teodor Lukac
Carsten Benecke
Richard Buchecker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rolic Technologies Ltd
Original Assignee
Rolic AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolic AG filed Critical Rolic AG
Assigned to ROLIC AG reassignment ROLIC AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LUKAC, TEODOR, BUCHECKER, RICHARD, BENECKE, CARSTEN
Application granted granted Critical
Publication of US6733690B1 publication Critical patent/US6733690B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/32Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/20Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers
    • C09K19/2007Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers the chain containing -COO- or -OCO- groups
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/38Polymers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0448Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0477Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by the positioning of substituents on phenylene
    • C09K2019/0481Phenylene substituted in meta position
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/20Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers
    • C09K19/2007Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters or ethers the chain containing -COO- or -OCO- groups
    • C09K2019/2078Ph-COO-Ph-COO-Ph

Definitions

  • the present invention relates to laterally substituted curable Liquid Crystals (LCPs) having mesogenic properties or properties which cause these LCPs to be compatible with a mesogenic molecular structure.
  • LCPs laterally substituted curable Liquid Crystals
  • the present invention relates to laterally substituted curable Liquid Crystals (LCPs) with adjustable optical anisotropy and in parallel with low melting point or good supercoolability, relatively high clearing point and good alignment properties and the use of such LCPs in the preparation of substantially uniform or patterned film in which the orientation of the LCP molecules in the plane and relative to the plane of the substrate can be controlled.
  • LCP films films prepared from curable Liquid Crystals
  • U.S. Pat. No. 5,650,534 discloses compounds and mixtures used to prepare components suitable for use non-linear optical (NLO) applications. These compounds are optically active and exhibit chiral smectic or chiral nematic mesophases.
  • U.S. Pat. No. 5,707,544 also discloses compounds and mixtures suitable for use in NLO applications. However, these compounds are characterised by relatively high melting points.
  • U.S. Pat. No. 5,593,617 discloses photochemically polymerisable liquid crystal compounds and mixtures, which are used to prepare optical and electronic components. However, these mixtures have a relatively narrow operating range and are unsuitable for use at higher temperatures.
  • LCP films are generally manufactured by using known coating techniques such as spin coating. This involves casting an organic solution of a cross-linkable LCP or LCP mixture onto a substrate provided with an orientation layer. The organic solvent is subsequently removed to give a well-oriented, solvent-free mesogenic LCP layer, which in turn is cross-linked to give an LCP film.
  • the desired optical performance of such films depends crucially on some reproducible physical parameters which the LCP material has to fulfill simultaneously.
  • Such properties are a nematic mesophase, a high clearing point, a low melting point or a low tendency to crystallise when cooled below melting point (supercooling), good solubility in organic solvents, good miscibility with other LCPs, good aligning properties on orientation layers, and the ability to form an adjustable tilt out of the substrate plane essentially free of tilt domains and disclinations.
  • Tilt domains are regions within the LCP film in which the long axes of the LCP molecules form tilt angles out of the plane of the substrate of the same size but in opposite direction.
  • Disclinations are borderlines of neighbouring tilt domains where LCP molecules of opposite tilt angles are adjacent. These tilt domains and disclinations result in both a disturbance in the uniform appearance of the film and an inhomogeneous optical performance.
  • LCP linear photo-polymerisation
  • LCPs For adjusting the optical properties of the layers and films prepared from LCPs as for example retardation films, it is further essential to have available a variety of LCP materials with differing optical anisotropy, mainly high optical anisotropy. It is known that LCPs exhibiting a high optical anisotropy often show a negative impact on several of the above properties. Particularly the formation of smectic mesophases, high melting points, an enhanced tendency to crystallise, a low solubility in organic solvents or reduced miscibility with other LCPs is observed. Furthermore the ability of homogeneous alignment free of tilt domains and disclinations is often reduced.
  • a first aspect of the invention provides a compound of formula (I)
  • G 1 and G 2 independently represent a polymerisable mesogenic residue
  • X represents a group selected from —CH 2 —, —O—, —CO—, —COO—, —OOC—, —CONR′—, —OCOO—, —OCONR′;
  • Sp represents a group of the formula —(CH 2 ) p — in which p is an integer of 1 to 18 and in which one or two non adjacent —CH 2 — groups are optionally replaced by —CH ⁇ CH—; or in which one or two —CH 2 — groups are optionally replaced by one or two groups selected from the group consisting of —O—, —CO—, —COO—, —OOC—, —CONR′—, —OCOO—, —OCONR′ with the proviso that firstly the spacer group does not contain two adjacent heteroatoms and secondly when X is —CH 2 —, p can also have a value of 0; and
  • M represents an achiral group of formula (II)
  • a and B independently represent a six membered isocyclic or heterocyclic group or naphthalenediyl
  • C is selected from the group consisting of a five and six membered isocyclic or heterocyclic group or naphthalenediyl;
  • n 1 and n 2 are 0 or 1 with the proviso that firstly 1 ⁇ n 1 +n 2 ⁇ 2 and secondly, when C is naphthalenediyl 0 ⁇ n 1 +n 2 ⁇ 2;
  • Z 1 is selected from the group consisting of —O—, —COO—, —OOC—, —CO—, —CONR′—, —NR′CO—, OCOO—, —OCONR′—, —NR′COO— and a single bond;
  • R′ is selected from the group consisting of hydrogen, a lower achiral alkyl group and a lower achiral alkenyl group;
  • Z 2 and Z 3 are independently selected from the group consisting of single bond, —COO—, —OOC—, —CH 2 —CH 2 —, —CH 2 O—, —OCH 2 —, —CH ⁇ CH—, —C ⁇ C—, —(CH 2 ) 4 — and —(CH 2 ) 3 O—; and
  • R 1 is selected from the group consisting of —CN, —COR, —COOR, —OCOR, —CONR′R, —NR′COR, OCOOR, —OCONR′R, —NR′COOR, —F, —Cl, —CF 3 , —OCF 3 , —OR and —R
  • R is selected from the group consisting of hydrogen, an achiral C 1-18 alkyl group and an achiral C 4-18 is alkenyl group with the double bond at 3-position or higher;
  • R′ is as defined above;
  • optical anisotropy of the compounds of the invention may be easily adapted to requirements only by selecting different groups of M of formula I without changing the main core of the molecule. This allows an economical access to a broad range of LCPs exhibiting different optical anisotropies with a minimum of chemical steps in their production.
  • the polymerisable mesogenic residues G 1 and G 2 may be the same or different, but are preferably the same.
  • the group X is preferably selected from the group consisting of —CH 2 —, —O—, —COO— and —OOC—.
  • the spacer group Sp may be optionally substituted by one or more fluorine or chlorine atoms. Groups in which there are no substituent groups present are preferred. It is especially preferred that the integer p has a value of from 1to 12 and that no more than two —CH 2 — groups are replaced by —O— and that no more than one —CH 2 — group is replaced by one group selected from the group consisting of —CH ⁇ CH—, —CO—, —COO—, —OOC—, —CONR′—, —OCOO— and —OCONR′.
  • the groups A and B comprising the achiral group M are either saturated, unsaturated or aromatic. They are optionally substituted by one or two substituents selected from the group consisting of F, Cl, CN, a lower alkyl, lower alkenyl, lower alkoxy and lower alkenyloxy. Preferably the groups A and B each contain no more that one substituent. It is especially preferred that the groups A and B contain no substitution.
  • the groups A and B are selected from the group consisting of 1,4-phenylene, pyridine-2,5-diyl, pyrimidine-2,5-diyl, trans-1,4-cyclohexylene or trans-1,3-dioxane-2,5-diyl, 1,4-naphthalenediyl and 2,6-naphthalenediyl.
  • a and B are selected from the group consisting of 1,4-phenylene, trans-1,4-cyclohexylene and 2,6-naphthalenediyl.
  • the group C comprising the achiral group M is either saturated, unsaturated or aromatic. It is optionally substituted with one or two substituents selected from the group consisting of F, Cl, CN, a lower alkyl, lower alkenyl, lower alkoxy and lower alkenyloxy. It is preferred that the group C contains at most one substituent. It is especially preferred that the group C contains no substitution.
  • the group C is selected from furan-2,4-diyl, furan-2,5-diyl, tetrahydrofuran-2,4-diyl, tetrahydrofuran-2,5-diyl, dioxolane-2,4-diyl, dioxolane-2,5-diyl, oxazole-2,4-diyl, oxazole-2,5-diyl, cyclopentane-1,3-diyl, cyclopentane-1,4-diyl, 1,4-phenylene, pyridine-2,5-diyl, pyrimidine-2,5-diyl, trans-1,4-cyclohexylene or dioxane-2,5-diyl, 1,4-naphthalenediyl and 2,6-naphthalenediyl.
  • C is selected from the group consisting of furan-2,5-diyl, tetrahydrofuran-2,5-diyl, oxazole-2,5-diyl, 1,4-phenylene, trans-1,4-cyclohexylene, and 2,6-naphthalenediyl.
  • the group Z 1 comprising the achiral group M is preferably selected from the group consisting of —O—, —COO—, —OOC— and a single bond. It is especially preferred that Z 1 is selected from —O— or a single bond.
  • the groups Z 2 and Z 3 comprising the achiral group M are preferably selected from the group consisting of —COO—, —OOC—, —CH 2 CH 2 —, —CH 2 O—, —OCH 2 —, —CH ⁇ CH—, —C ⁇ C— and a single bond. It is especially preferred that Z 2 and Z 3 are selected from the group consisting of —COO—, —OOC—, —C ⁇ C— and a single bond.
  • the group R 1 comprising the achiral group M is preferably selected from the group consisting of —CN, —COOR, —OCOR, F, Cl, CF 3 , OCF 3 , OR, R, in which R represents a C 1-12 achiral alkyl, C 4-12 achiral alkenyl group with the double bond at position 3- or higher, or hydrogen. It is especially preferred that R 1 is selected from the group consisting of —CN, F, Cl, CF 3 , OCF 3 , OR, R, in which R represents a C 1-8 achiral alkyl group or hydrogen.
  • lower alkyl it should be understood to include a C 1-6 achiral, branched or straight-chained alkyl group.
  • Examples of lower alkyl groups that may be present in the compounds of the invention include methyl, ethyl, propyl, butyl, pentyl hexyl and the like.
  • lower alkenyl it should be understood to include C 3-6 achiral, branched or straight-chained alkenyl group in which the double bond is at position 2- or higher.
  • Examples of lower alkenyl groups that may be present in the compounds of the invention include 2-propenyl, 3-butenyl, 3-isopentenyl, 4-pentenyl, 5-hexenyl, 4-isohexenyl and the like.
  • lower alkoxy it should be understood to include C 1-6 ; achiral, branched or straight-chained alkoxy group.
  • Examples of lower alkoxy groups that may be present in the compounds of the invention include methoxy, ethoxy, propoxy, butoxy, pentoxy hexoxy and the like.
  • alkenyloxy it should be understood to include C 3-6 achiral, branched or straight-chained alkenyloxy group in which the double bond is at position 2- or higher.
  • Examples of lower alkenyloxy groups that may be present in the compounds of the invention include 2-propenyloxy, 3-butenyloxy, 4-pentenyloxy, 5-hexenyloxy and the like.
  • polymerisable mesogenic residues G 1 and G 2 are each independently represented by the group of formula III
  • D and E are independently selected from the group consisting of 1,4-phenylene, pyridine-2,5-diyl, pyrimidine-2,5-diyl, trans-1,4-cyclohexylene and trans-1,3-dioxane-2,5-diyl;
  • n 1 or 0,
  • Z 4 and Z 5 are independently selected from the group consisting of a single bond, —COO—, —OOC—, —CH 2 —CH 2 —, —CH 2 O—, —OCH 2 —, —CH ⁇ CH—, —C ⁇ C—, —(CH 2 ) 4 — and —(CH 2 ) 3 O—;
  • Z 6 represent a group of formula —(CH 2 ) p X— in which p is an integer having a value of 1 to 18 and X is defined above, and in which one or two non adjacent —CH 2 — groups may be optionally replaced by —CH ⁇ CH— or in which one or two —CH 2 — groups may be replaced by one or two additional linking groups X with the proviso that firstly the group Z 6 does not contain two adjacent heteroatoms and secondly when X is —CH 2 , p can also have a value of 0
  • R 2 represents a polymerisable group selected from the group consisting of CH 2 ⁇ C(Ph)—, CH 2 ⁇ CW—COO—, CH 2 ⁇ CH—COO—Ph—, CH 2 ⁇ CW—CO—NH—, CH 2 ⁇ CH—O—, CH 2 ⁇ CH—OOC—, Ph—CH ⁇ CH—, CH 2 ⁇ CH—Ph—, CH 2 ⁇ CH—Ph—O—, R 3 —Ph—CH ⁇ CH—COO—, R 3 —OOC—CH ⁇ CH—Ph—O— and 2-W-epoxyethyl
  • W represents H, Cl, Ph or a lower alkyl
  • R 3 represents a lower alkyl with the proviso that when R 3 is attached to a phenylene group (—Ph—) it may also represent hydrogen or a lower alkoxy.
  • Ph and “Ph—” will be understood to indicate a phenyl group.
  • —Ph— will be understood to mean any isomer of phenylene, namely 1,2-phenylene, 1,3-phenlylene or 1,4-phenylene, except where the context requires otherwise.
  • the groups D and E are optionally substituted with one or two halogens, —CN, lower alkyl, lower alkenyl, lower alkoxy or lower alkenyloxy groups. If halogen substituents are present they are preferably F or Cl. It is preferred that the groups D and E are selected from optionally substituted 1,4-phenylene and 1,4-cyclohexylene rings. It is especially preferred that the groups D and E contain no substitution.
  • the groups Z 4 and Z 5 are selected from the group consisting of a single bond, —COO—, —OOC—, —CH 2 —CH 2 —, —CH 2 O—, —OCH 2 —, —CH ⁇ CH— and —C ⁇ C—. It is especially preferred that Z 4 and Z 5 represent a single bond, —C ⁇ C—, —COO—or —OOC—.
  • Z 6 may be optionally substituted by one or more halogen atoms, preferably one or more fluorine atoms. It is preferred that p has a value of 1 to 11. It is also preferred that Z 6 contains no substitution. It is further preferred that, for the group Z 6 , X is selected from —CH 2 —, —O—, —COO— and —OOC—, especially —CH 2 — or —O—.
  • the group R 2 is selected from the group consisting of CH 2 ⁇ CW—COO— and CH 2 ⁇ CH—O—.
  • the sum of the two integers m for each of the groups G 1 and G 2 is 0 or 1. It is especially preferred that for both G 1 and G 2 m has a value of 0.
  • DEAD is diethyl azodicarboxylate
  • TPP is triphenylphospine
  • THF is tetrahydrofuran
  • DBU is 1,8-diazabicyclo[5.4.0]undec-7-ene
  • EDC is N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride
  • Suitable starting materials used in the preparation of the compounds of the present invention include, amongst others, phenyl and biphenyl alcohol and carboxylic acid compounds as well as 1,4-cyclohexanedione.
  • the starting materials are commercially available or may be readily prepared and are well known to a skilled person.
  • the compounds of the invention are preferably prepared by forming a ring that includes a lateral group prior to linking the mesogenic residues.
  • the compounds may be prepared by forming a ring that includes a polymerisable mesogenic residue prior to linking the lateral group.
  • a second aspect of the invention therefore provides a method of preparation of a compound of formula (I), the method comprising forming a ring that includes a lateral group and subsequently linking the mesogenic residue thereto.
  • the mesogenic residues G 1 and G 2 are preferably connected to the central ring simultaneously. As indicated above, it is especially preferred that the mesogenic residues G 1 and G 2 are identical.
  • the compounds of the invention may be used in the preparation of liquid crystalline mixtures. Such mixtures may be prepared by admixing a compound of formula (I) with one or more additional components. An organic solvent may also be used in the preparation of these mixtures.
  • a third aspect of the invention therefore provides a liquid crystalline mixture comprising a compound of formula (I) and one or more additional components.
  • the one or more additional components present in the liquid crystalline mixture may be further compounds of formula (I), other mesogenic compounds, compounds that are compatible with a mesogenic molecular architecture or chiral dopants for the induction of helical pitch.
  • the LCP mixture may also include a suitable organic solvent. Examples of solvents that may be used in the preparation of such liquid crystalline mixtures include anisole, N-methylmorpholine, caprolactone, cyclohexanone, methyl ethyl ketone and the like.
  • Examples of additional components that may be used in the preparation of liquid crystalline LCP mixtures according to the third aspect of the invention include those compounds represented by formulae III to X.
  • R 4 is selected from the group consisting of CH 2 ⁇ CH—O—, CH 2 ⁇ CH—COO—, CH 2 ⁇ C(CH 3 )—COO—, CH 2 ⁇ C(Cl)—COO— and
  • S 3 , S 4 independently represent —(CH 2 ) n — or —O(CH 2 ) n —;
  • E 1 , E 2 are independently selected from the group consisting of 1,4-phenylene trans-1,4-cyclohexylene, pyridine-2,5-diyl, pyrimidine-2,5-diyl and trans 1,4-cyclohexylene-1,4-phenylene;
  • F 1 , F 2 are independently selected from the group consisting of 1,4-phenylene, and 2- or 3-fluoro-1,4-phenylene;
  • L 4 , L 5 , L 6 are independently selected from the group consisting of OH, C 1 -C 20 -alkyl, C 1 -C 20 -alkenyl, C 1 -C 20 -alkoxy, C 1 -C 20 -alkoxy-carbonyl, formyl, C 1 -C 20 -alkylcarbonyl, C 1 -C 20 -alkylcarbonyloxy, halogen, cyano and nitro;
  • Z 7 is selected from the group consisting of —COO—, —OOC—, —OCH 2 —, —CH 2 O—, —O(CH 2 ) 3 —, —OOC(CH 2 ) 2 — and —COO(CH 2 ) 3 —;
  • Z 8 is selected from the group consisting of a single bond, —CH 2 CH 2 —, —CH 2 O—, —OCH 2 —, —COO—, —OOC—, —(CH 2 ) 4 —, —O(CH 2 ) 3 —, (CH 2 ) 3 O— and —C ⁇ C—;
  • Z 9 is selected from the group consisting of a single bond, —CH 2 CH 2 —, —CH 2 O—, —OCH 2 —, —COO—, —OOC—, and —C ⁇ C—;
  • Y is independently selected from the group consisting of hydroxy, C 1 -C 20 -alkyl, C 1 -C 20 -alkenyl, C 1 -C 20 -alkoxy, C 1 -C 20 -alkoxycarbonyl, formyl-, C 1 -C 20 -alkylcarbonyl, C 1 -C 20 -alkylcarbonyloxy, fluoro, chloro, bromo, cyano and nitro;
  • n is an integer having a value of from 2 to 20;
  • v is an integer having a value of from 2 to 12
  • the compounds of the invention may also be used in the formation of a LCP layer by casting a LCP compound according to the first aspect of the invention or a mixture according to the third aspect of the invention onto a substrate.
  • a fourth aspect of the invention therefore provides a method forming a LCP network comprising forming a LCP layer including a compound of formula (I) and cross-linking the layer.
  • Liquid crystalline mixtures according to the third aspect of the invention may also be used in the manufacture of LCP networks in a similar way.
  • the invention also includes, in a fifth aspect of the invention, a cross-linked LCP network comprising a compound of formula (I) in a cross-linked form.
  • Cross-linked LCP networks comprising a mixture according to the third aspect of the invention in cross-linked form may also be included in this aspect of the invention.
  • a sixth aspect of the invention provides the use of a compound of formula (I) in the preparation of an optical or an electro-optical device.
  • the use, in the preparation of an optical or electro-optical device, of liquid crystalline mixtures according to the third aspect of the invention is also included in this aspect of the invention.
  • a seventh aspect of the invention provides an optical or an electro-optical device comprising a compound of formula (I) in a cross-linked state.
  • An optical or electro-optical device comprising a LCP liquid crystalline mixture in a cross-linked state according to the third aspect of the invention is also included in this aspect of the invention.
  • the well oriented film shows the nematic mesophase at room temperature.
  • This nematic film also shows a well oriented nematic mesophase at room temperature with a clearing point of about 85° C. In addition this film exhibits a tilt angle of about 1° relative to the plane of the substrate, as shown by ellipsometric measurements.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

In one embodiment, the invention relates to compounds of the formula (I)
Figure US06733690-20040511-C00001
wherein G1 and G2 independently represent a polymerisable mesogenic residue, X and Sp are as defined herein and M represents an achiral group of formula (II)
Figure US06733690-20040511-C00002
as defined herein. The compounds of the invention may, for example, be useful as curable liquid crystals and for preparing liquid crystal films.

Description

This application is a national stage filing under 35 U.S.C. §371 of international application no. PCT/IB00/00158, filed on Feb. 15, 2000, which published in the English language. This application also claims the benefit of priority under 35 U.S.C. §119(a) to GB patent application no. 9906168.1, filed on Mar. 17, 1999.
The present invention relates to laterally substituted curable Liquid Crystals (LCPs) having mesogenic properties or properties which cause these LCPs to be compatible with a mesogenic molecular structure. In particular the present invention relates to laterally substituted curable Liquid Crystals (LCPs) with adjustable optical anisotropy and in parallel with low melting point or good supercoolability, relatively high clearing point and good alignment properties and the use of such LCPs in the preparation of substantially uniform or patterned film in which the orientation of the LCP molecules in the plane and relative to the plane of the substrate can be controlled.
Films prepared from curable Liquid Crystals (LCP films) are well known to a skilled person and are used in the preparation of optical and electro-optical devices. U.S. Pat. No. 5,650,534 discloses compounds and mixtures used to prepare components suitable for use non-linear optical (NLO) applications. These compounds are optically active and exhibit chiral smectic or chiral nematic mesophases. U.S. Pat. No. 5,707,544 also discloses compounds and mixtures suitable for use in NLO applications. However, these compounds are characterised by relatively high melting points. U.S. Pat. No. 5,593,617 discloses photochemically polymerisable liquid crystal compounds and mixtures, which are used to prepare optical and electronic components. However, these mixtures have a relatively narrow operating range and are unsuitable for use at higher temperatures.
LCP films are generally manufactured by using known coating techniques such as spin coating. This involves casting an organic solution of a cross-linkable LCP or LCP mixture onto a substrate provided with an orientation layer. The organic solvent is subsequently removed to give a well-oriented, solvent-free mesogenic LCP layer, which in turn is cross-linked to give an LCP film. The desired optical performance of such films depends crucially on some reproducible physical parameters which the LCP material has to fulfill simultaneously. Such properties are a nematic mesophase, a high clearing point, a low melting point or a low tendency to crystallise when cooled below melting point (supercooling), good solubility in organic solvents, good miscibility with other LCPs, good aligning properties on orientation layers, and the ability to form an adjustable tilt out of the substrate plane essentially free of tilt domains and disclinations. Tilt domains are regions within the LCP film in which the long axes of the LCP molecules form tilt angles out of the plane of the substrate of the same size but in opposite direction. Disclinations are borderlines of neighbouring tilt domains where LCP molecules of opposite tilt angles are adjacent. These tilt domains and disclinations result in both a disturbance in the uniform appearance of the film and an inhomogeneous optical performance.
Good aligning properties and the ability to form an adjustable tilt angle are of particular relevance if photo-orientated and photo-patterned orientation layers are used for the orientation of LCPs. This so-called linear photo-polymerisation (LPP) technology (cf. e.g. Nature, 381, p. 212 (1996)) allows the production of not only uniform but also structured (photo-patterned) orientation layers. If such structured orientation layers are used for the orientation of LCPs, the LCP molecules should adapt the information given by the orientation layer with respect to the direction of alignment and the tilt angle.
For adjusting the optical properties of the layers and films prepared from LCPs as for example retardation films, it is further essential to have available a variety of LCP materials with differing optical anisotropy, mainly high optical anisotropy. It is known that LCPs exhibiting a high optical anisotropy often show a negative impact on several of the above properties. Particularly the formation of smectic mesophases, high melting points, an enhanced tendency to crystallise, a low solubility in organic solvents or reduced miscibility with other LCPs is observed. Furthermore the ability of homogeneous alignment free of tilt domains and disclinations is often reduced.
There is, therefore, a need for a new LCP material that may be used in the preparation of an LCP mixture, which significantly reduces the aforementioned disadvantages. The present invention addresses that need.
A first aspect of the invention provides a compound of formula (I)
Figure US06733690-20040511-C00003
wherein
G1 and G2 independently represent a polymerisable mesogenic residue;
X represents a group selected from —CH2—, —O—, —CO—, —COO—, —OOC—, —CONR′—, —OCOO—, —OCONR′;
Sp represents a group of the formula —(CH2)p— in which p is an integer of 1 to 18 and in which one or two non adjacent —CH2— groups are optionally replaced by —CH═CH—; or in which one or two —CH2— groups are optionally replaced by one or two groups selected from the group consisting of —O—, —CO—, —COO—, —OOC—, —CONR′—, —OCOO—, —OCONR′ with the proviso that firstly the spacer group does not contain two adjacent heteroatoms and secondly when X is —CH2—, p can also have a value of 0; and
M represents an achiral group of formula (II)
Figure US06733690-20040511-C00004
 in which
A and B independently represent a six membered isocyclic or heterocyclic group or naphthalenediyl;
C is selected from the group consisting of a five and six membered isocyclic or heterocyclic group or naphthalenediyl;
n1 and n2 are 0 or 1 with the proviso that firstly 1≦n1+n2≦2 and secondly, when C is naphthalenediyl 0≦n1+n2≦2;
Z1 is selected from the group consisting of —O—, —COO—, —OOC—, —CO—, —CONR′—, —NR′CO—, OCOO—, —OCONR′—, —NR′COO— and a single bond;
 in which
R′ is selected from the group consisting of hydrogen, a lower achiral alkyl group and a lower achiral alkenyl group;
Z2 and Z3 are independently selected from the group consisting of single bond, —COO—, —OOC—, —CH2—CH2—, —CH2O—, —OCH2—, —CH═CH—, —C≡C—, —(CH2)4— and —(CH2)3O—; and
R1 is selected from the group consisting of —CN, —COR, —COOR, —OCOR, —CONR′R, —NR′COR, OCOOR, —OCONR′R, —NR′COOR, —F, —Cl, —CF3, —OCF3, —OR and —R
 in which
R is selected from the group consisting of hydrogen, an achiral C1-18 alkyl group and an achiral C4-18 is alkenyl group with the double bond at 3-position or higher; and
R′ is as defined above;
with the proviso that at most one of the rings A, B and C is a naphthalenediyl group.
In addition to the laterally substituted mesogenic compounds referred to above, such compounds are also disclosed in WO 95/24454 and WO 95/24455. However, many of these compounds are not suitable for preparing LCP films with high optical anisotropy without one or more of the aforementioned disadvantages. It has been found that by using the compounds of the present invention it is possible to control the optical anisotropy of LCPs without significant increase of melting point or decrease of clearing point. In addition they generally have a surprisingly low tendency to crystallise even far below the melting point (good supercoolability). Furthermore they generally exhibit enhanced alignment properties especially on structured LPP orientation layers, they are able to form tilt angles and show a decreased tendency to form tilt domains and disclinations. Furthermore the compounds of the invention have a comparatively good solubility in organic solvents and a high miscibility with other LCP compounds.
The optical anisotropy of the compounds of the invention may be easily adapted to requirements only by selecting different groups of M of formula I without changing the main core of the molecule. This allows an economical access to a broad range of LCPs exhibiting different optical anisotropies with a minimum of chemical steps in their production.
The polymerisable mesogenic residues G1 and G2 may be the same or different, but are preferably the same.
The group X is preferably selected from the group consisting of —CH2—, —O—, —COO— and —OOC—.
The spacer group Sp may be optionally substituted by one or more fluorine or chlorine atoms. Groups in which there are no substituent groups present are preferred. It is especially preferred that the integer p has a value of from 1to 12 and that no more than two —CH2— groups are replaced by —O— and that no more than one —CH2— group is replaced by one group selected from the group consisting of —CH═CH—, —CO—, —COO—, —OOC—, —CONR′—, —OCOO— and —OCONR′.
The groups A and B comprising the achiral group M are either saturated, unsaturated or aromatic. They are optionally substituted by one or two substituents selected from the group consisting of F, Cl, CN, a lower alkyl, lower alkenyl, lower alkoxy and lower alkenyloxy. Preferably the groups A and B each contain no more that one substituent. It is especially preferred that the groups A and B contain no substitution.
It is preferred that the groups A and B are selected from the group consisting of 1,4-phenylene, pyridine-2,5-diyl, pyrimidine-2,5-diyl, trans-1,4-cyclohexylene or trans-1,3-dioxane-2,5-diyl, 1,4-naphthalenediyl and 2,6-naphthalenediyl. Is it especially preferred that A and B are selected from the group consisting of 1,4-phenylene, trans-1,4-cyclohexylene and 2,6-naphthalenediyl.
The group C comprising the achiral group M is either saturated, unsaturated or aromatic. It is optionally substituted with one or two substituents selected from the group consisting of F, Cl, CN, a lower alkyl, lower alkenyl, lower alkoxy and lower alkenyloxy. It is preferred that the group C contains at most one substituent. It is especially preferred that the group C contains no substitution.
It is preferred that the group C is selected from furan-2,4-diyl, furan-2,5-diyl, tetrahydrofuran-2,4-diyl, tetrahydrofuran-2,5-diyl, dioxolane-2,4-diyl, dioxolane-2,5-diyl, oxazole-2,4-diyl, oxazole-2,5-diyl, cyclopentane-1,3-diyl, cyclopentane-1,4-diyl, 1,4-phenylene, pyridine-2,5-diyl, pyrimidine-2,5-diyl, trans-1,4-cyclohexylene or dioxane-2,5-diyl, 1,4-naphthalenediyl and 2,6-naphthalenediyl. It is especially preferred that C is selected from the group consisting of furan-2,5-diyl, tetrahydrofuran-2,5-diyl, oxazole-2,5-diyl, 1,4-phenylene, trans-1,4-cyclohexylene, and 2,6-naphthalenediyl.
The group Z1 comprising the achiral group M is preferably selected from the group consisting of —O—, —COO—, —OOC— and a single bond. It is especially preferred that Z1 is selected from —O— or a single bond.
The groups Z2 and Z3 comprising the achiral group M are preferably selected from the group consisting of —COO—, —OOC—, —CH2CH2—, —CH2O—, —OCH2—, —CH═CH—, —C≡C— and a single bond. It is especially preferred that Z2 and Z3 are selected from the group consisting of —COO—, —OOC—, —C≡C— and a single bond.
The group R1 comprising the achiral group M is preferably selected from the group consisting of —CN, —COOR, —OCOR, F, Cl, CF3, OCF3, OR, R, in which R represents a C1-12 achiral alkyl, C4-12 achiral alkenyl group with the double bond at position 3- or higher, or hydrogen. It is especially preferred that R1 is selected from the group consisting of —CN, F, Cl, CF3, OCF3, OR, R, in which R represents a C1-8 achiral alkyl group or hydrogen.
By the term “lower alkyl” it should be understood to include a C1-6 achiral, branched or straight-chained alkyl group. Examples of lower alkyl groups that may be present in the compounds of the invention include methyl, ethyl, propyl, butyl, pentyl hexyl and the like.
By the term “lower alkenyl” it should be understood to include C3-6 achiral, branched or straight-chained alkenyl group in which the double bond is at position 2- or higher. Examples of lower alkenyl groups that may be present in the compounds of the invention include 2-propenyl, 3-butenyl, 3-isopentenyl, 4-pentenyl, 5-hexenyl, 4-isohexenyl and the like.
By the term “lower alkoxy” it should be understood to include C1-6; achiral, branched or straight-chained alkoxy group. Examples of lower alkoxy groups that may be present in the compounds of the invention include methoxy, ethoxy, propoxy, butoxy, pentoxy hexoxy and the like.
By the term “alkenyloxy” it should be understood to include C3-6 achiral, branched or straight-chained alkenyloxy group in which the double bond is at position 2- or higher. Examples of lower alkenyloxy groups that may be present in the compounds of the invention include 2-propenyloxy, 3-butenyloxy, 4-pentenyloxy, 5-hexenyloxy and the like.
Preferably the polymerisable mesogenic residues G1 and G2 are each independently represented by the group of formula III
Figure US06733690-20040511-C00005
wherein
D and E are independently selected from the group consisting of 1,4-phenylene, pyridine-2,5-diyl, pyrimidine-2,5-diyl, trans-1,4-cyclohexylene and trans-1,3-dioxane-2,5-diyl;
m is 1 or 0,
Z4 and Z5 are independently selected from the group consisting of a single bond, —COO—, —OOC—, —CH2—CH2—, —CH2O—, —OCH2—, —CH═CH—, —C≡C—, —(CH2)4— and —(CH2)3O—;
Z6 represent a group of formula —(CH2)pX— in which p is an integer having a value of 1 to 18 and X is defined above, and in which one or two non adjacent —CH2— groups may be optionally replaced by —CH═CH— or in which one or two —CH2— groups may be replaced by one or two additional linking groups X with the proviso that firstly the group Z6 does not contain two adjacent heteroatoms and secondly when X is —CH2, p can also have a value of 0
R2 represents a polymerisable group selected from the group consisting of CH2═C(Ph)—, CH2═CW—COO—, CH2═CH—COO—Ph—, CH2═CW—CO—NH—, CH2═CH—O—, CH2═CH—OOC—, Ph—CH═CH—, CH2═CH—Ph—, CH2═CH—Ph—O—, R3—Ph—CH═CH—COO—, R3—OOC—CH═CH—Ph—O— and 2-W-epoxyethyl
 in which
W represents H, Cl, Ph or a lower alkyl,
R3 represents a lower alkyl with the proviso that when R3 is attached to a phenylene group (—Ph—) it may also represent hydrogen or a lower alkoxy.
The terms “Ph” and “Ph—” will be understood to indicate a phenyl group. The term “—Ph—” will be understood to mean any isomer of phenylene, namely 1,2-phenylene, 1,3-phenlylene or 1,4-phenylene, except where the context requires otherwise.
The groups D and E are optionally substituted with one or two halogens, —CN, lower alkyl, lower alkenyl, lower alkoxy or lower alkenyloxy groups. If halogen substituents are present they are preferably F or Cl. It is preferred that the groups D and E are selected from optionally substituted 1,4-phenylene and 1,4-cyclohexylene rings. It is especially preferred that the groups D and E contain no substitution.
It is preferred that the groups Z4 and Z5 are selected from the group consisting of a single bond, —COO—, —OOC—, —CH2—CH2—, —CH2O—, —OCH2—, —CH═CH— and —C≡C—. It is especially preferred that Z4 and Z5 represent a single bond, —C≡C—, —COO—or —OOC—.
Z6 may be optionally substituted by one or more halogen atoms, preferably one or more fluorine atoms. It is preferred that p has a value of 1 to 11. It is also preferred that Z6 contains no substitution. It is further preferred that, for the group Z6, X is selected from —CH2—, —O—, —COO— and —OOC—, especially —CH2— or —O—.
It is preferred that the group R2 is selected from the group consisting of CH2═CW—COO— and CH2═CH—O—.
It is preferred that the sum of the two integers m for each of the groups G1 and G2 is 0 or 1. It is especially preferred that for both G1 and G2 m has a value of 0.
The compounds of the invention may be readily prepared using procedures well known to a skilled person in accordance with any one of the procedures set out in Schemes 1 and 2 below.
Figure US06733690-20040511-C00006
Figure US06733690-20040511-C00007
in which:
DEAD is diethyl azodicarboxylate
TPP is triphenylphospine
THF is tetrahydrofuran
KI is potassium iodide
DBU is 1,8-diazabicyclo[5.4.0]undec-7-ene
EDC is N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride
DMAP is 4-dimethylaminopyridine
Suitable starting materials used in the preparation of the compounds of the present invention include, amongst others, phenyl and biphenyl alcohol and carboxylic acid compounds as well as 1,4-cyclohexanedione. The starting materials are commercially available or may be readily prepared and are well known to a skilled person.
The compounds of the invention are preferably prepared by forming a ring that includes a lateral group prior to linking the mesogenic residues. Alternatively, the compounds may be prepared by forming a ring that includes a polymerisable mesogenic residue prior to linking the lateral group. A second aspect of the invention therefore provides a method of preparation of a compound of formula (I), the method comprising forming a ring that includes a lateral group and subsequently linking the mesogenic residue thereto. The mesogenic residues G1 and G2 are preferably connected to the central ring simultaneously. As indicated above, it is especially preferred that the mesogenic residues G1 and G2 are identical.
It will be appreciated that the compounds of the invention may be used in the preparation of liquid crystalline mixtures. Such mixtures may be prepared by admixing a compound of formula (I) with one or more additional components. An organic solvent may also be used in the preparation of these mixtures. A third aspect of the invention therefore provides a liquid crystalline mixture comprising a compound of formula (I) and one or more additional components. The one or more additional components present in the liquid crystalline mixture may be further compounds of formula (I), other mesogenic compounds, compounds that are compatible with a mesogenic molecular architecture or chiral dopants for the induction of helical pitch. The LCP mixture may also include a suitable organic solvent. Examples of solvents that may be used in the preparation of such liquid crystalline mixtures include anisole, N-methylmorpholine, caprolactone, cyclohexanone, methyl ethyl ketone and the like.
Examples of additional components that may be used in the preparation of liquid crystalline LCP mixtures according to the third aspect of the invention include those compounds represented by formulae III to X.
Figure US06733690-20040511-C00008
Figure US06733690-20040511-C00009
in which
R4 is selected from the group consisting of CH2═CH—O—, CH2═CH—COO—, CH2═C(CH3)—COO—, CH2═C(Cl)—COO— and
Figure US06733690-20040511-C00010
S3, S4 independently represent —(CH2)n— or —O(CH2)n—;
E1, E2 are independently selected from the group consisting of 1,4-phenylene trans-1,4-cyclohexylene, pyridine-2,5-diyl, pyrimidine-2,5-diyl and trans 1,4-cyclohexylene-1,4-phenylene;
F1, F2 are independently selected from the group consisting of 1,4-phenylene, and 2- or 3-fluoro-1,4-phenylene;
L4, L5, L6 are independently selected from the group consisting of OH, C1-C20-alkyl, C1-C20-alkenyl, C1-C20-alkoxy, C1-C20-alkoxy-carbonyl, formyl, C1-C20-alkylcarbonyl, C1-C20-alkylcarbonyloxy, halogen, cyano and nitro;
Z7 is selected from the group consisting of —COO—, —OOC—, —OCH2—, —CH2O—, —O(CH2)3—, —OOC(CH2)2— and —COO(CH2)3—;
Z8 is selected from the group consisting of a single bond, —CH2CH2—, —CH2O—, —OCH2—, —COO—, —OOC—, —(CH2)4—, —O(CH2)3—, (CH2)3O— and —C≡C—;
Z9 is selected from the group consisting of a single bond, —CH2CH2—, —CH2O—, —OCH2—, —COO—, —OOC—, and —C≡C—;
Y is independently selected from the group consisting of hydroxy, C1-C20-alkyl, C1-C20-alkenyl, C1-C20-alkoxy, C1-C20-alkoxycarbonyl, formyl-, C1-C20-alkylcarbonyl, C1-C20-alkylcarbonyloxy, fluoro, chloro, bromo, cyano and nitro;
n is an integer having a value of from 2 to 20; and
v is an integer having a value of from 2 to 12
The compounds of the invention may also be used in the formation of a LCP layer by casting a LCP compound according to the first aspect of the invention or a mixture according to the third aspect of the invention onto a substrate. A fourth aspect of the invention therefore provides a method forming a LCP network comprising forming a LCP layer including a compound of formula (I) and cross-linking the layer. Liquid crystalline mixtures according to the third aspect of the invention may also be used in the manufacture of LCP networks in a similar way.
The invention also includes, in a fifth aspect of the invention, a cross-linked LCP network comprising a compound of formula (I) in a cross-linked form. Cross-linked LCP networks comprising a mixture according to the third aspect of the invention in cross-linked form may also be included in this aspect of the invention.
A sixth aspect of the invention provides the use of a compound of formula (I) in the preparation of an optical or an electro-optical device. The use, in the preparation of an optical or electro-optical device, of liquid crystalline mixtures according to the third aspect of the invention is also included in this aspect of the invention.
A seventh aspect of the invention provides an optical or an electro-optical device comprising a compound of formula (I) in a cross-linked state. An optical or electro-optical device comprising a LCP liquid crystalline mixture in a cross-linked state according to the third aspect of the invention is also included in this aspect of the invention.
The invention will now be described with reference to the following non-limiting examples. These examples are provided by way of illustration only. Variations on these examples falling within the scope of the invention will be apparent to a skilled person.
EXAMPLES Example 1 Synthesis of 8-Chlorooctyl-4-(4′-octylbiphenyl) ether
Figure US06733690-20040511-C00011
A solution of diethyl azodicarboxylate (2.1 g; 12 mmol) tetrahydrofuran (10 ml) was added dropwise at 0° C. to a solution of 4-octyl-4′-hydroxybiphenyl (3.2 g; 11.3 mmol), 8-chlorooctanol (1.9 g; 12 mmol), triphenylphosphine (3.2 g; 12 mmol) and tetrahydrofuran (80 ml) and stirred at room temperature overnight. The reaction mixture was added to water (200 ml) and extracted with ethyl acetate (3×100 ml). The combined organic layers were washed with water (2×100 ml), dried over magnesium sulphate and filtered. The solvent was removed in vacuo. The residue (11.1 g) was purified by flash chromatography on silica gel column using a toluene/ethyl acetate mixture (95:5) as eluent to give 4.4 g (93%) of 8-Chlorooctyl-4-(4′-octylbiphenyl) ether.
Synthesis of 8[(4′-Octyl-4-biphenylyl)oxy]octyl 2,5-dihydroxybenzoate
Figure US06733690-20040511-C00012
A mixture of 2,5-dihydroxybenzoic acid (1.7 g; 11.0 mmol), 1,8-diazabicyclo-[5.4.0]undec-7-ene (1.7 g; 11.0 mmol), 8-chlorooctyl-4′-octyl-4-biphenyl ether (4.4 g; 10.2 mmol), potassium iodide (6.6 g; 40.0 mmol) and acetonitrile (150 ml) was heated under reflux for 72 h. The reaction mixture was cooled, poured into water (600 ml) and extracted with ethyl acetate (3×150 ml). The combined organic layers were washed with 1N-hydrochloric acid (150 ml) and water (2×150 ml), dried over magnesium sulphate and filtered. The solvent was removed in vacuo. The residue (4.9 g) was purified by recrystallisation from ethyl acetate/toluene to give 4.5 g (80%) of 8-[(4′-octyl-4-biphenylyl)oxy]octyl 2,5-dihydroxybenzoate.
Synthesis of [[[8-[(4′-Octyl-4-biphenyl)oxy]octyl]oxy]carbonyl]-p-phenylene bis[p-[[6-(acryloyloxy)hexyl]oxy]benzoate]
Figure US06733690-20040511-C00013
A solution of N-(3-dimethylaminopropyl)-N′-ethyl-carbodiimide hydrochloride (2.6 g; 13.7 mmol) in dichloromethane (50 ml) was added slowly to a solution of 8-[(4′-octyl-4-biphenylyl)oxy]octyl-2,5-dihydroxybenzoate (3.0 g; 5.5 mmol), 4-(6-acryloyl-hexyloxy)benzoic acid (4.1 g; 13.7 mmol) and 4-dimethylaminopyridine (1.3 g; 10.9 mmol) in dichloromethane (100 ml) at 0° C. The mixture was stirred at room temperature overnight, added to water (200 ml) and extracted with dichloromethane (3×100 ml). The combined organic layers were washed with water (2×100 ml), dried over magnesium sulphate and filtered. The solvent was removed in vacuo. The residue (8.4 g) was purified by flash chromatography on silica gel column using a toluene/ethyl acetate mixture (95:5) as eluent. Recrystallisation from ethyl acetate/hexane gave 2.2 g (38%) of [[[8-[(4′-octyl-4-biphenyl)oxy]octyl]oxy]carbonyl]-p-phenylene bis[p-[[6-(acryloyl-oxy)hexyl]oxy]benzoate]. Mp (C—N)=89.5° C.; Clp (N—I)=103° C.
The following compounds were synthesised using a similar method.
2,5-bis-[4-(6-Acryloyloxyhexyloxy)benzoyloxy]benzoic Acid 8-[4-(5-Octylpyridin-2-yl)phenoxy]nonyl Ester
Figure US06733690-20040511-C00014
Mp (C—N)=61° C.; Clp (N—I)=89° C.
[[[9-[p-(5-Nonyl-2-pyrimidinyl)phenoxy]nonyl]oxy]carbonyl]-p-phenylene bis[p-[[6-(acryloyloxy)hexyl]oxy]benzoate]
Figure US06733690-20040511-C00015
Mp (C—N)=55.5° C.; Clp (N—I)=90.2° C.
[[[8-[p-(Trans-4-pentylcyclohexyl)phenoxy]octyl]oxy]carbonyl]-p-phenylene bis[p-[[6-(acryloyloxy)hexyl]oxy]benzoate]
Figure US06733690-20040511-C00016
[[[[8-[(4′-Cyano-4-biphenylyl)oxy]octyl]oxy]carbonyl]-p-phenylene bis[p-[[6-(acryloyloxy)hexyl]oxy]benzoate]
Figure US06733690-20040511-C00017
Mp (C—N)=72° C.; Clp (N—I)=114.7° C. Solubility in MPK: 7.2%
2,5-Bis[4-(6-acryloyloxyhexyloxy)benzoyloxy]benzoic Acid 8-(6-Pentyloxy-2-naphthyloxy)octyl Ester
Figure US06733690-20040511-C00018
[[2-[2-[(4′Cyano-4-biphenyl)oxy]ethoxy]ethoxy]carbonyl]-p-phenylene bis[p-[6-(Acryloyloxy)hexyloxy]benzoate
Figure US06733690-20040511-C00019
Mp. (C—N)=54° C.; Clp (N—I)=86° C.; Solubility, in MPK: 33.2%
2,5-Bis[4-(6-acryloyloxyhexyloxy)benzoyloxy]benzoic Acid 6-[4-[(4-Cyanophenyl) ethinyl]phenyloxy]hexyl Ester
Figure US06733690-20040511-C00020
Mp. (C—N)=71.4° C.; Clp (N—I)=130.6C;
2,5-Bis[4-(6-acryloyloxy)hexyloxy)benzoyloxy]benzoic Acid 8-(2-Naphthyloxy)octyl Ester
Figure US06733690-20040511-C00021
Mp. (C—N)=63° C.; Clp (N—I)=74° C.; This compound may be supercooled
Example 2 Synthesis of 4′-[(8-Chlorooctyl)oxy]-4-biphenylol
Figure US06733690-20040511-C00022
A solution of diethyl azodicarboxylate (3.5 g; 20 mmol) and tetrahydrofuran (10 ml) was added dropwise at 0° C. to a solution of 4,4′-dihydroxybiphenyl (7.4 g; 40 mmol), 8-chloro-1-octanol (3.3 g; 20 mmol), triphenylphosphine (5.2 g; 20 mmol) and tetrahydrofuran (120 ml) and stirred at room temperature 72 h. The reaction mixture was added to water (400 ml) and extracted with ethyl acetate (3×150 ml). The combined organic layers were washed with water (2×150 ml), dried over magnesium sulphate and filtered. The solvent was removed in vacuo. The residue (19.2 g) was purified by flash chromatography on a silica gel column using a toluene/ethyl acetate mixture (95:5) as eluent, to give 2.6 g (40%) of 4′-[(8-chlorooctyl)oxy]-4-biphenylol.
Synthesis of 4′-[(8-Chlorooctyl)oxy]-4-biphenylyl 2-furoate
Figure US06733690-20040511-C00023
A solution of 2-furoyl chloride (1.3 g; 9.8 mmol) was added dropwise at 0° C. to a solution of 4′-[(8-chlorooctyl)oxy]-4-biphenylol (2.6 g; 7.8 mmol) and pyridine (20 g; 253 mmol), stirred at room temperature overnight. The resulting mixture was added to 1N-hydrochloric acid (200 ml) and extracted with ethyl acetate (3×100 ml). The combined organic layers were washed with saturated sodium chloride solution (2×80 ml), dried over magnesium sulphate and filtered. The solvent was removed in vacuo. The residue (3.3 g) was purified by recrystallisation from ethyl acetate/hexane, to give 2.9 g (88%) of 4-[(8-Chlorooctyl)oxy]-4-biphenylyl-2-furoate.
Synthesis of {[8-[(2,5-Dihydroxybenzoyl)oxy]octyl]oxy}-4-biphenylyl 2-furoate
Figure US06733690-20040511-C00024
A mixture of 2,5-dihydroxybenzoic acid (1.1 g; 7.0 mmol), 1.8-diazabicyclo-[5.4.0]undec-7-ene (1.1 g; 7.0 mmol), 4′-[(8-chlorooctyl)oxy]-4biphenyl-2-furoate (2.9 g; 6.8 mmol), potassium iodide (5.2 g; 35 mmol) and acetonitrile (100 ml) was heated under reflux for 48 h. The cooled reaction mixture was poured into water (500 ml) and extracted with ethyl acetate (3×150 ml). The combined organic layers were washed with 1N-hydrochloric acid (100 ml) and water (2×100 ml), dried over magnesium sulphate and filtered. The solvent was removed in vacuo. The residue (2.8 g) was purified by flash chromatography on a silica gel column using a toluene/ethyl acetate mixture (93:7) as eluent to give 1.1 g (30%) of {[8-[(2,5-dihydroxybenzoyl)oxy]octyl]oxy}-4-biphenylyl-2-furoate.
Synthesis of Furan-2-carboxylic Acid 4′-(8-{2,5-bis-[4-(6-Acryloyloxyhexyloxy)-benzoyloxy]benzoyloxy}octyloxy)biphenyl-4-yl Ester
Figure US06733690-20040511-C00025
A solution of N-(3-dimethylaminopropyl)-N′-ethyl-carbodiimide hydrochloride (1.0 g; 5.1 mmol) in dichloromethane (20 ml) was slowly added to a solution of 4′-{[8-[(2,5-dihydroxybenzoyl)oxy]octyl]oxy}-4-biphenylyl-2-furoate (1.1 g; 2.0 mmol), 4-(6-acryloylhexyloxy)benzoic acid (1.5 g; 5.0 mmol) and 4-dimethylaminopyridine (0.5 g; 3.9 mmol) in dichloromethane (30 ml) at 0° C. The mixture was stirred overnight at room temperature, added to water (200 ml) and extracted with dichloromethane (3×100 ml). The organic layers were washed with water (2×80 ml), dried over magnesium sulphate and filtered. The solvent was removed in vacuo. The residue (2.6 g) was purified by flash chromatography on a silica gel column using a toluene/ethyl acetate mixture (90:10) as eluent. Recrystallisation from ethyl acetate/isopropanol gave 0.4 g (19%) of furan-2-carboxylic acid 4′-8-{2,5-bis[4-(6-acryloyloxyhexyloxy)benzoyloxy]-benzoyloxy}octyloxy)biphenyl-4-yl ester.
Mp (C—N)=89.5° C.; Clp=103° C. The compound is supercoolable below room temperature.
2,5-Bis[4-(6-acryloyloxyhexyloxy)benzoyloxy]benzoic Acid 8-[6-[(4-Octyloxyphenyl)ethinyl]-2-naphthyloxy]hexyl Ester
Figure US06733690-20040511-C00026
Mp. (C—N)=67° C.; Clp (N—I)=145° C.; This compound may be supercooled
2,5-Bis[4-(6-acryloyloxyhexyloxy)benzoyloxy]benzoic Acid 8-[6-[(4-Cyanophenyl) ethinyl]-2-naphthyloxy]octyl Ester
Figure US06733690-20040511-C00027
Mp. (C—N)=103° C.; Clp (N—I)=142° C.; This compound may be supercooled
[[2-[2-[2-[(4-Cyanophenyl)ethinyl]-6-naphthyloxy]ethoxy]ethoxy]carbonyl]-p-phenylene bis[p-[6-(acryloyloxy)hexyloxy]benzoate
Figure US06733690-20040511-C00028
Mp. (C—N)=90° C.; Clp (N—I)=133° C.; This compound may be supercooled
[[2-[2-[4′-[(4-Cyanophenyl)ethinyl]-4-biphenyloxy]ethoxy]ethoxy]carbonyl]-p-phenylene bis[p-[6-(acryloyloxy)hexyloxy]benzoate
Figure US06733690-20040511-C00029
Mp. (C—N)=93° C.; Clp (N—I)=177° C.; This compound may be supercooled
Example 3 Preparation of Nematic LCP films
(i) A mixture of the following components in anisole was prepared:
60 wt % of
Figure US06733690-20040511-C00030
20 wt % of
Figure US06733690-20040511-C00031
10 wt % of
Figure US06733690-20040511-C00032
and 10 wt % of 1,4-butanediol diacrylate as a promoter of forming a polymer network. Further 500 ppm of 2,6-di-(t-butyl)-4-hydroxytoluene (BHT) inhibitor were added to this mixture in order to prevent untimely polymerisation. Polymerisation was started using 500 ppm initiator such as Irgacure 369 (commercially available from Ciba Geigy, Basle, Switzerland). The mixture was stirred at room temperature and than spincoated on a glass plate having an orientation layer to form an LCP film of ca. 800 nm in thickness. This film was dried at 50° C. for 1 or 2 minutes and photopolymerised by irradiation with UV light for approximately 5 minutes at room temperature in a N2 atmosphere using a mercury lamp.
The well oriented film shows the nematic mesophase at room temperature.
(ii) A mixture of the following components in Anisole was prepared according to the procedure of Example 1
60 wt % of
Figure US06733690-20040511-C00033
20 wt % of
Figure US06733690-20040511-C00034
10 wt % of
Figure US06733690-20040511-C00035
and 10 wt % of 1,4-butanediol diacrylate (Aldrich).
This nematic film also shows a well oriented nematic mesophase at room temperature with a clearing point of about 85° C. In addition this film exhibits a tilt angle of about 1° relative to the plane of the substrate, as shown by ellipsometric measurements.

Claims (21)

What is claimed is:
1. A compound of formula (I)
Figure US06733690-20040511-C00036
wherein
G1 and G2 independently represent a polymerisable mesogenic residue;
X represents a group selected from —CH2—, —O—, —CO—, —COO—, —OOC—, —CONR′—, —OCOO—, —OCONR′;
Sp represents a group of the formula —(CH2)p— in which p is an integer of 1 to 18 and in which one or two non adjacent —CH2— groups are optionally replaced by —CH═CH—; or in which one or two —CH2— groups are optionally replaced by one or two groups selected from the group consisting of —O—, —CO—, —COO—, —OOC—, —CONR′—, —OCOO—, and —OCONR′ with the proviso that firstly the spacer group does not contain two adjacent heteroatoms and secondly when X is —CH2—, p can also have a value of 0; and
M represents an achiral group of formula (II)
Figure US06733690-20040511-C00037
 in which
A and B independently represent an optionally substituted six membered isocyclic or heterocyclic group or naphthalenediyl;
C is selected from the group consisting of an optionally substituted five and six membered isocyclic or heterocyclic group or naphthalenediyl;
n1 and n2 are 0 or 1 with the proviso that firstly 1≦n1+n2≦2 and secondly, when C is naphthalenediyl 0≦n1+n2≦2;
Z1 is selected from the group consisting of —O—, —COO—, —OOC—, —CO—, —CONR′—, —NR′CO—, OCOO—, —OCONR′—, —NR′COO— and a single bond;
 in which
R′ is selected from the group consisting of hydrogen, a lower achiral alkyl group and a lower achiral alkenyl group;
Z2 and Z3 are independently selected from the group consisting of a single bond, —COO—, —OOC—, —CH2—CH2—, —CH2O—, —OCH2—, —CH═CH—, —C≡C—, —(CH2)4—, and —(CH2)3O—; and
R1 is selected from the group consisting of —CN, —COR, —COOR, —OCOR, —CONR′R, —NR′COR, OCOOR, —OCONR′R, —NR′COOR, —F, —Cl, —CF3, —OCF3, —OR and —R
 in which
R is selected from the group consisting of hydrogen, an achiral C1-18 alkyl group and an achiral C4-18 alkenyl group with the double bond at 3-position or higher; and
R′ is a defined above;
with the proviso that at most one of the rings A, B and C is a naphthalenediyl group.
2. A compound according to claim 1, in which G1 and G2 are the same.
3. A compound according to claim 1, in which X is selected from —CH2—, —O—, —COO— and —OOC—.
4. A compound according to claim 1, in which the integer p of the group Sp has a value of from 1 to 12.
5. A compound according to claim 1, in which one or two —CH2— groups in Sp are replaced by —O—.
6. A compound according to claim 1, in which no more than one —CH2— group in Sp is replaced by a group selected from the group consisting of —CH═CH—, —CO—, —COO—, —OOC—, —CONR′—, —OCOO— and —OCONR′.
7. A compound according to claim 1, in which the groups A and B are selected from the group consisting of 1,4-phenylene, pyridine-2,5-diyl, pyrimidine-2,5-diyl, trans-1,4-cyclohexylene or trans-1,3-dioxane-2,5-diyl, 1,4-naphthalenediyl and 2,6-naphthalenediyl.
8. A compound according to claim 1, in which the group C is selected from furan-2,4-diyl, furan-2,5-diyl, tetrahydrofuran-2,4-diyl, tetrahydrofuran-2,5-diyl, dioxolane-2,4-diyl, dioxolane-2,5-diyl, oxazole-2,4-diyl, oxazole-2,5-diyl, cyclopentane-1,3-diyl, cyclopentane-1,4-diyl, 1,4-phenylene, pyridine-2,5-diyl, pyrimidine-2,5-diyl, trans-1,4-cyclohexylene or dioxane-2,5-diyl, and 2,6-naphthalenediyl.
9. A compound according to claim 1, in which the group Z1 is selected from the group consisting of —O—, —COO—, —OOC— and a single bond.
10. A compound according to claim 1, in which the groups Z2 and Z3 are independently selected from the group consisting of —COO—, —OOC—, —CH2CH2—, —CH2O—, —OCH2—, —CH═CH—, —C≡C— and a single bond.
11. A compound according to claim 1, in which the group R1 is selected from the group consisting of —CN, —COOR, —OCOR, F, Cl, CF3, OCF3, OR, and R, in which R represents a C1-12 achiral alkyl, or C4-12 achiral alkenyl group, with the double bond at position 3- or higher, or hydrogen.
12. A compound according to claim 1, in which the polymerisable mesogenic residues G1 and G2 are each independently represented by the group of formula III
Figure US06733690-20040511-C00038
wherein
D and E are independently selected from the group consisting of optionally substituted 1,4-phenylene, pyridine-2,5-diyl, pyrimidine -2,5-diyl, trans-1,4-cyclohexylene and trans-1,3-dioxane-2,5-diyl;
m is 1 or 0,
Z4 and Z5 are independently selected from the group consisting a single bond, —COO—, —OOC—, —CH2—CH2—, —CH2O—, —OCH2—, —CH═CH—, —C≡C—, —(CH2)4— and —(CH2)3O—;
Z6 represents a group of formula —(CH2)pX— in which p is an integer having a value of 1 to 18 and X is as defined in claim 1, and in which one or two non adjacent —CH2— groups may be optionally replaced by —CH═CH— or in which one or two —CH2— groups may be replaced by one or two additional linking groups X with the proviso that firstly the group Z6 does not contain two adjacent heteroatoms and secondly when X is —CH2, p can also have a value of 0
R2 represents a polymerisable group selected from the group consisting of CH2═C(Ph)—, CH2═CW—COO—, CH2═CH—COO—Ph—, CH2═CW—CO—NH—, CH2═CH—O—, CH2═CH—OOC—, Ph—CH═CH—, CH2═CH—Ph—, CH2═CH—Ph —O—, R3—Ph—CH═CH—COO—, R3—OOC—CH═CH—Ph—O— and 2-W- epoxyethyl
 in which
W represents H, Cl, Ph or a lower alkyl,
R3 represents a lower alkyl with the proviso that when R3 is attached to a phenylene group (—Ph—) it may also represent hydrogen or a lower alkoxy.
13. A compound according to claim 12, in which the groups D and E are independently selected from optionally substituted 1,4-phenylene and 1,4-cyclohexylene rings.
14. A compound according to claim 12, in which Z4 and Z5 are selected from the group consisting of a single bond, —COO—, —OOC—, —CH2—CH2—, —CH2O—, —OCH2—, —CH═CH— and —C≡C—.
15. A compound according to claim 12, in which the group R2 is selected from the group consisting of CH2═CW—COO— and CH2═CH—O—.
16. An optical or electro-optical device comprising a compound according to claim 1.
17. A LCP network, comprising a compound according to claim 1 in cross-linked or polymerised form.
18. An optical or electro-optical device comprising a network according to claim 17.
19. A LCP mixture comprising a compound of formula (I)
Figure US06733690-20040511-C00039
wherein
G1 and G2 independently represent a polymerisable mesogenic residue;
X represents a group selected from —CH2—, —O—, —CO—, —COO—, —OOC—, —CONR′—, —OCOO—, and —OCONR′—;
Sp represents a group of the formula —(CH2)p— in which p is an integer of 1 to 18 and in which one or two non adjacent —CH2— groups are optionally replaced by —CH═CH—; or in which one or two —CH2— groups are optionally replaced by one or two groups selected from the group consisting of —O—, —CO—, —COO—, —OOC—, —CONR′—, —OCOO—, and —OCONR′ with the proviso that firstly the spacer group does not contain two adjacent heteroatoms and secondly when X is —CH2—, p can also have a value of 0; and
M represents an achiral group of formula (II)
Figure US06733690-20040511-C00040
 in which
A and B independently represent an optionally substituted six membered isocyclic or heterocyclic group or naphthalenediyl;
C is selected from the group consisting of an optionally substituted five and six membered isocyclic or heterocyclic group or naphthalenediyl;
n1 and n2 are 0 or 1 with the proviso that firstly 1≦n1+n2≦2 and secondly, when C is naphthalenediyl 0≦n1+n2≦2;
Z1 is selected from the group consisting of —O—, —COO—, —OOC—, —CO—, —CONR′—, —NR′CO—, OCOO—, —OCONR′—, —NR′COO— and a single bond;
 in which
R′ is selected from the group consisting of hydrogen, a lower achiral alkyl group and a lower achiral alkenyl group;
Z2 and Z3 are independently selected from the group consisting of a single bond, —COO—, —OOC—, —CH2—CH2—, —CH2O—, —OCH2—, —CH═CH—, —C≡C—, —(CH2)4— and —(CH2)3O—; and
R1 is selected from the group consisting of —CN, —COR, —COOR, —OCOR, —CONR′R, —NR′COR, OCOOR, —OCONR′R, —NR′COOR, —F, Cl, —CF3, —OCF3, —OR and —R
 in which
R is selected from the group consisting of hydrogen, an achiral C1-18 alkyl and an achiral C4-18 alkenyl group with the double bond at 3- position or higher; and
R′ is as defined above;
with the proviso that at most one of the rings A, B and C is a naphthalenediyl group and one or more additional suitable components.
20. A LCP network, comprising a mixture according to claim 19 in cross-linked on polymerised form.
21. An optical or electro-optical device comprising a mixture according to claim 19.
US09/936,725 1999-03-17 2000-02-15 Laterally substituted curable liquid crystals Expired - Lifetime US6733690B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9906168.1A GB9906168D0 (en) 1999-03-17 1999-03-17 Liquid crystal compounds
GB9906168 1999-03-17
PCT/IB2000/000158 WO2000055110A1 (en) 1999-03-17 2000-02-15 Liquid crystal compounds

Publications (1)

Publication Number Publication Date
US6733690B1 true US6733690B1 (en) 2004-05-11

Family

ID=10849823

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/936,725 Expired - Lifetime US6733690B1 (en) 1999-03-17 2000-02-15 Laterally substituted curable liquid crystals

Country Status (10)

Country Link
US (1) US6733690B1 (en)
EP (1) EP1169293B1 (en)
JP (1) JP4834226B2 (en)
KR (1) KR100750822B1 (en)
CN (1) CN1213018C (en)
AU (1) AU2456500A (en)
DE (1) DE60042589D1 (en)
GB (1) GB9906168D0 (en)
HK (1) HK1039318A1 (en)
WO (1) WO2000055110A1 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030028048A1 (en) * 1999-12-23 2003-02-06 Cherkaoui Zoubair Mohammed Optically active materials
US20050040364A1 (en) * 2001-09-24 2005-02-24 Cherkaoui Zoubair Mohammed Liquid crystalline laterally polymerizable compounds
US20070257230A1 (en) * 2003-12-04 2007-11-08 Cherkaoui Zoubair M Additive Components for Liquid Crystalline Materials
US20090323011A1 (en) * 2008-06-27 2009-12-31 Transitions Optical, Inc. Mesogen containing compounds
US20090323012A1 (en) * 2008-06-27 2009-12-31 Transitions Opitcal, Inc. Liquid crystal compositions comprising mesogen containing compounds
US20100059709A1 (en) * 2006-12-22 2010-03-11 Rolic Ag Patternable liquid crystal polymer comprising thio-ether units
US20100266821A1 (en) * 2007-12-21 2010-10-21 Rolic Ag Functionalized photoreactive compounds
US20100266814A1 (en) * 2007-12-21 2010-10-21 Rolic Ag Photoalignment composition
EP2272937A1 (en) 2009-07-09 2011-01-12 Rolic AG Ester group containing compounds for optical or electro optical devices
WO2011003846A1 (en) 2009-07-09 2011-01-13 Rolic Ag Ester group containing liquid crystals for optical or electro optical devices
US20110216273A1 (en) * 2008-06-27 2011-09-08 Transitions Optical, Inc. Mesogen-containing compounds
US8054411B2 (en) 2006-09-13 2011-11-08 Rolic Ag Volume photo-aligned retarder
US8349210B2 (en) 2008-06-27 2013-01-08 Transitions Optical, Inc. Mesogenic stabilizers
US8431039B2 (en) 2008-06-27 2013-04-30 Transitions Optical, Inc. Mesogenic stabilizers
US8613868B2 (en) 2008-06-27 2013-12-24 Transitions Optical, Inc Mesogenic stabilizers
US8623238B2 (en) 2008-06-27 2014-01-07 Transitions Optical, Inc. Mesogenic stabilizers
US8884034B2 (en) 2009-07-08 2014-11-11 Dermira (Canada), Inc. TOFA analogs useful in treating dermatological disorders or conditions
WO2018019691A1 (en) 2016-07-29 2018-02-01 Rolic Ag Method for generating alignment on top of a liquid crystal polymer material
WO2021013780A1 (en) 2019-07-24 2021-01-28 Rolic Technologies AG Photo-alignable positive c-plate retarder
US20220127531A1 (en) * 2019-04-08 2022-04-28 Rolic Technologies AG Liquid crystal compounds

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908934D0 (en) * 1999-04-19 1999-06-16 Rolic Ag Liquid crystalline compounds
US6919946B2 (en) 2002-04-16 2005-07-19 3M Innovative Properties Company Compensators for liquid crystal displays and the use and manufacture of the compensators
JP2006282579A (en) * 2005-03-31 2006-10-19 Nippon Oil Corp Liquid crystalline (meth)acrylic compound having alkoxynaphthyl group and polymer thereof
JP5151479B2 (en) * 2005-04-13 2013-02-27 旭硝子株式会社 Polymerizable liquid crystal composition, optically anisotropic material, optical element and optical head device
US10385215B2 (en) 2014-05-21 2019-08-20 Rolic Ag Polymerizable dichroic dyes
WO2019206846A1 (en) 2018-04-25 2019-10-31 Basf Se Process for the production of strongly adherent liquid crystal films on flexible substrates
WO2021032518A1 (en) 2019-08-19 2021-02-25 Basf Se A process for the production of fingerprint texture free liquid crystal films

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164111A (en) * 1986-06-27 1992-11-17 Merck Patent Gesellschaft Mit Beschraenkter Haftung Polymerizable liquid-crystal material and polymers exhibiting liquid-crystal phases
EP0748852A2 (en) 1995-06-07 1996-12-18 F. Hoffmann-La Roche Ag Photocrosslinkable liquid crystalline dyestuffs
US5593617A (en) * 1994-09-12 1997-01-14 Hoffmann-Laroche Inc. Photochemically polymerizable liquid crystals
WO1999037735A1 (en) 1998-01-27 1999-07-29 Rolic Ag Liquid-crystalline photocrosslinkable mixture
WO1999064924A1 (en) 1998-06-11 1999-12-16 Rolic Ag Optical component, orientation layer, and layerable polymerisable mixture
WO2000004110A1 (en) 1998-07-14 2000-01-27 Rolic Ag Compositions
US6319963B1 (en) * 1998-08-26 2001-11-20 Merck Patent Gesellschaft Mit Beschrankter Haftung Reflective film

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59508765D1 (en) * 1994-08-31 2000-11-09 Rolic Ag Zug Optically active smectic photocrosslinkable liquid crystals
GB9817272D0 (en) * 1998-08-07 1998-10-07 Rolic Ag Liquid crystalline compounds
GB9903670D0 (en) * 1999-02-17 1999-04-14 Rolic Ag Liquid crystal compounds

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164111A (en) * 1986-06-27 1992-11-17 Merck Patent Gesellschaft Mit Beschraenkter Haftung Polymerizable liquid-crystal material and polymers exhibiting liquid-crystal phases
US5593617A (en) * 1994-09-12 1997-01-14 Hoffmann-Laroche Inc. Photochemically polymerizable liquid crystals
EP0748852A2 (en) 1995-06-07 1996-12-18 F. Hoffmann-La Roche Ag Photocrosslinkable liquid crystalline dyestuffs
US5707544A (en) 1995-06-07 1998-01-13 Rolic Ag Chromophore-containing photo cross-linkable liquid crystals
WO1999037735A1 (en) 1998-01-27 1999-07-29 Rolic Ag Liquid-crystalline photocrosslinkable mixture
WO1999064924A1 (en) 1998-06-11 1999-12-16 Rolic Ag Optical component, orientation layer, and layerable polymerisable mixture
WO2000004110A1 (en) 1998-07-14 2000-01-27 Rolic Ag Compositions
US6319963B1 (en) * 1998-08-26 2001-11-20 Merck Patent Gesellschaft Mit Beschrankter Haftung Reflective film

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6905739B2 (en) * 1999-12-23 2005-06-14 Rolic Ag Optically active materials
US20030028048A1 (en) * 1999-12-23 2003-02-06 Cherkaoui Zoubair Mohammed Optically active materials
US20050040364A1 (en) * 2001-09-24 2005-02-24 Cherkaoui Zoubair Mohammed Liquid crystalline laterally polymerizable compounds
US20070257230A1 (en) * 2003-12-04 2007-11-08 Cherkaoui Zoubair M Additive Components for Liquid Crystalline Materials
US8105662B2 (en) * 2003-12-04 2012-01-31 Rolic Ag Additive components for liquid crystalline materials
US8054411B2 (en) 2006-09-13 2011-11-08 Rolic Ag Volume photo-aligned retarder
US20100059709A1 (en) * 2006-12-22 2010-03-11 Rolic Ag Patternable liquid crystal polymer comprising thio-ether units
US8574454B2 (en) 2006-12-22 2013-11-05 Rolic Ag Patternable liquid crystal polymer comprising thio-ether units
US20100266821A1 (en) * 2007-12-21 2010-10-21 Rolic Ag Functionalized photoreactive compounds
US20100266814A1 (en) * 2007-12-21 2010-10-21 Rolic Ag Photoalignment composition
US9499649B2 (en) 2007-12-21 2016-11-22 Rolic Ag Functionalized photoreactive compounds
US9715144B2 (en) 2007-12-21 2017-07-25 Rolic Ag Photoalignment composition
US10558089B2 (en) 2007-12-21 2020-02-11 Rolic Ag Photoalignment composition
US8349210B2 (en) 2008-06-27 2013-01-08 Transitions Optical, Inc. Mesogenic stabilizers
US20090323011A1 (en) * 2008-06-27 2009-12-31 Transitions Optical, Inc. Mesogen containing compounds
US7910019B2 (en) 2008-06-27 2011-03-22 Transitions Optical, Inc. Mesogen containing compounds
US7910020B2 (en) 2008-06-27 2011-03-22 Transitions Optical, Inc. Liquid crystal compositions comprising mesogen containing compounds
US8431039B2 (en) 2008-06-27 2013-04-30 Transitions Optical, Inc. Mesogenic stabilizers
US20110216273A1 (en) * 2008-06-27 2011-09-08 Transitions Optical, Inc. Mesogen-containing compounds
US8613868B2 (en) 2008-06-27 2013-12-24 Transitions Optical, Inc Mesogenic stabilizers
US8623238B2 (en) 2008-06-27 2014-01-07 Transitions Optical, Inc. Mesogenic stabilizers
US8628685B2 (en) 2008-06-27 2014-01-14 Transitions Optical, Inc Mesogen-containing compounds
US20090323012A1 (en) * 2008-06-27 2009-12-31 Transitions Opitcal, Inc. Liquid crystal compositions comprising mesogen containing compounds
US9434718B2 (en) 2009-07-08 2016-09-06 Dermira (Canada), Inc. TOFA analogs useful in treating dermatological disorders or conditions
US8884034B2 (en) 2009-07-08 2014-11-11 Dermira (Canada), Inc. TOFA analogs useful in treating dermatological disorders or conditions
US9782382B2 (en) 2009-07-08 2017-10-10 Dermira (Canada), Inc. TOFA analogs useful in treating dermatological disorders or conditions
US8951616B2 (en) 2009-07-09 2015-02-10 Rolic Ag Ester group containing liquid crystals for optical or electro optical devices
EP2272937A1 (en) 2009-07-09 2011-01-12 Rolic AG Ester group containing compounds for optical or electro optical devices
WO2011003846A1 (en) 2009-07-09 2011-01-13 Rolic Ag Ester group containing liquid crystals for optical or electro optical devices
WO2018019691A1 (en) 2016-07-29 2018-02-01 Rolic Ag Method for generating alignment on top of a liquid crystal polymer material
US11181674B2 (en) 2016-07-29 2021-11-23 Rolic Technologies AG Method for generating alignment on top of a liquid crystal polymer material
US12044872B2 (en) 2016-07-29 2024-07-23 Rolic Technologies AG Method for generating alignment on top of a liquid crystal polymer material
US20220127531A1 (en) * 2019-04-08 2022-04-28 Rolic Technologies AG Liquid crystal compounds
US11959005B2 (en) * 2019-04-08 2024-04-16 Rolic Technologies AG Liquid crystal compounds
WO2021013780A1 (en) 2019-07-24 2021-01-28 Rolic Technologies AG Photo-alignable positive c-plate retarder

Also Published As

Publication number Publication date
AU2456500A (en) 2000-10-04
JP4834226B2 (en) 2011-12-14
KR20020004966A (en) 2002-01-16
GB9906168D0 (en) 1999-05-12
WO2000055110A1 (en) 2000-09-21
CN1213018C (en) 2005-08-03
KR100750822B1 (en) 2007-08-22
JP2002539182A (en) 2002-11-19
EP1169293B1 (en) 2009-07-22
HK1039318A1 (en) 2002-04-19
EP1169293A1 (en) 2002-01-09
CN1344243A (en) 2002-04-10
DE60042589D1 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
US6733690B1 (en) Laterally substituted curable liquid crystals
US6676851B1 (en) Laterally substituted curable liquid crystals
US6746729B1 (en) Liquid crystal compounds
JP6797544B2 (en) Fluorinated dibenzofuran and dibenzothiophene derivatives
JP3954098B2 (en) Bireactive mesogenic compounds and intermediates
JP6552254B2 (en) 4,6-difluorodibenzothiophene derivatives
JP2002521354A (en) Crosslinkable liquid crystal compound
JP4577990B2 (en) Liquid crystal compound
KR100391860B1 (en) Photo-crosslinkable liquid crystal 1,4-dioxane-2,3-diyl derivative
US5417882A (en) Liquid-crystalline compounds
JP2593875B2 (en) Chiral ester consisting of an α-substituted phenylalkanoic acid and a mesogenic hydroxyl compound and use of the ester as a dopant in a liquid crystal composition
JPH09504788A (en) Liquid crystal compound
JP2013001683A (en) Liquid crystal compound having 2,6,7-trioxa-bicyclo[2.2.2]octane skeleton and liquid crystal composition
JP4402413B2 (en) U-shaped compound and liquid crystal composition containing the same
EP0427166B1 (en) Ester compounds and liquid crystal compositions containing the same
US5417884A (en) Defined oligomeric liquid-crystalline compounds having smectic liquid-crystalline phases
JP2925682B2 (en) Novel ester compound, liquid crystal composition containing the same, and optical switching element
JP2848471B2 (en) Optically active compound and liquid crystal composition containing the same
Wu et al. Novel Chiral Dopants Derived from (2 S)-2-(6-Hydroxy-2-naphthyl) propionic Acid for Ferroelectric Liquid Crystal Mixtures
JP2742548B2 (en) Optically active compound and liquid crystal composition containing the same
WO2000002856A1 (en) Chiral compounds and their use as doping agents in liquid crystals
JPH0791227B2 (en) Triester liquid crystal compound
JPH1067708A (en) 2-Methylsuccinic acid diester compound, liquid crystal composition containing the same, and method for producing this compound
JPH02233634A (en) Liquid crystal compound
JPH01254644A (en) Novel lactic acid derivative and liquid crystal composition containing said derivative

Legal Events

Date Code Title Description
AS Assignment

Owner name: ROLIC AG, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LUKAC, TEODOR;BENECKE, CARSTEN;BUCHECKER, RICHARD;REEL/FRAME:012290/0097;SIGNING DATES FROM 20010806 TO 20010829

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12